India to United States: Nivolumab Export Trade Route
India has recorded 10 verified shipments of Nivolumab exported to United States, representing a combined trade value of $4.9K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $486 USD. The leading Indian exporter is GNH India Pharmaceuticals Limited, which accounts for 73% of total export value with 1 shipments worth $3.5K USD. On the buying side, NA is the largest importer in United States with $3.5K USD in purchases. The top 3 suppliers — GNH India Pharmaceuticals Limited, DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Nivolumab corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $4.9K USD. The route is dominated by GNH India Pharmaceuticals Limited, which alone accounts for roughly 73% of all export value, reflecting the consolidated nature of India's nivolumab manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $486 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with nivolumab's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 32.3%, placing it at rank #16 among India's top nivolumab export destinations globally.
On the import side, key buyers of Indian nivolumab in United States include NA, CHARLES RIVER LABORATORIES, BIOPHARMASPEC INC and 3 others. NA is the single largest importer with 1 shipments valued at $3.5K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ4
- Primary modeSea freight
- Top portAHEMDABAD AIR
Market Position
- Global rank#16
- Annual growth+32.3%
- Demand growth+26.9%
- Regulatory ease72/100
Top 10 Indian Nivolumab Exporters to United States
Showing top 10 of 5 Indian suppliers exporting Nivolumab to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GNH India Pharmaceuticals Limited Avg $3.5K per shipment | 1 | $3.5K | 72.7% |
| 2 | DR.REDDY'S LABORATORIES LTD Avg $194 per shipment | 4 | $775 | 15.9% |
| 3 | DR REDDYS LABORATORIES LIMITED Avg $531 per shipment | 1 | $531 | 10.9% |
| 4 | ENZENE BIOSCIENCES LIMITED Avg $23 per shipment | 1 | $23 | 0.5% |
| 5 | INTAS PHARMACEUTICALS LIMITED Avg $0 per shipment | 3 | $0 | 0.0% |
This table shows the top 10 of 5 Indian companies exporting nivolumab to United States, ranked by total trade value. The listed exporters are: GNH India Pharmaceuticals Limited, DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, ENZENE BIOSCIENCES LIMITED, INTAS PHARMACEUTICALS LIMITED. GNH India Pharmaceuticals Limited is the dominant supplier with 1 shipments worth $3.5K USD, giving it a 73% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Nivolumab Importers in United States
Showing top 10 of 6 known buyers in United States receiving Nivolumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian nivolumab in United States include NA, CHARLES RIVER LABORATORIES, BIOPHARMASPEC INC, CHARLES RIVER LABORATORIES,INC.,, NIIMBL ,RM 301 LIFE SCIENCE BUILDI, among 6 total buyers. The largest importer is NA, accounting for $3.5K USD across 1 shipments — representing 73% of all nivolumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NA | 1 | $3.5K | 72.7% |
| 2 | CHARLES RIVER LABORATORIES | 1 | $531 | 10.9% |
| 3 | BIOPHARMASPEC INC | 3 | $525 | 10.8% |
| 4 | CHARLES RIVER LABORATORIES,INC., | 1 | $250 | 5.1% |
| 5 | NIIMBL ,RM 301 LIFE SCIENCE BUILDI | 1 | $23 | 0.5% |
| 6 | BIOPHARMA SPEC INC | 3 | $0 | 0.0% |
Top 10 Nivolumab Formulations Imported by United States
Showing top 10 of 10 product formulations shipped on the India to United States Nivolumab route, ranked by trade value
United States imports a wide range of nivolumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Opdyta 100mg Nivolumab Concentrate forSo — accounts for $3.5K USD across 1 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Opdyta 100mg Nivolumab Concentrate forSo | 1 | $3.5K | 72.7% |
| 2 | NIVOLUMAB BULK HARVEST50 ML FALCON TUBEQTY:60 NOSFOR TESTING SAMPLES ONLY | 1 | $531 | 10.9% |
| 3 | NIVOLUMAB TEST SAMPLE-3(DRL-NIVOLUMAB)-1ML(QTY:01 VIAL) | 1 | $287 | 5.9% |
| 4 | NIVOLUMAB WCB VIAL(1.8 ML CRYOVIAL)(QTY:10 VIALS)(FOR TESTING USE SAMPLES ONLY) | 1 | $250 | 5.1% |
| 5 | NIVOLUMAB TEST SAMPLE-1(OPDIVO REFERENCEMEDICINAL PRODUCT)-1ML(QTY:01 VIAL) | 1 | $124 | 2.5% |
| 6 | NIVOLUMAB TEST SAMPLE-2(OPDIVO REFERENCEMEDICINAL PRODUCT)-1ML(QTY:01 VIAL) | 1 | $114 | 2.3% |
| 7 | NIVOLUMAB DRUG PRODUCTS (240MG/24 ML EACH VIAL) | 1 | $23 | 0.5% |
| 8 | NIVOLUMABRMP OPDIVO 10MG/MLBATCH NO.: 8006210 300 MCLEXP. DATE : 08/24 | 1 | $0 | 0.0% |
| 9 | NIVOLUMABRMP OPDIVO 10MG/MLBATCH NO.: ACD5328 300 MCLEXP. DATE : 10/24 | 1 | $0 | 0.0% |
| 10 | NIVOLUMAB FORMULATION BUFFER 10 ML | 1 | $0 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
AHEMDABAD AIR handles the highest volume with 3 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's nivolumab exports to United States are driven primarily by a handful of large-scale manufacturers. GNH India Pharmaceuticals Limited with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GNH India Pharmaceuticals Limited, DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $486 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as nivolumab bulk harvest50 ml falcon tubeqty:60 nosfor testing samples only and nivolumab test sample-3(drl-nivolumab)-1ml(qty:01 vial), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NA is the largest importer with 1 shipments worth $3.5K USD — representing 73% of all nivolumab imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.9K
- Avg. Shipment
- $486
- Suppliers
- 5
- Buyers
- 6
- Transit (Sea)
- ~34 days
- Annual Growth
- +32.3%
Reverse Direction
United States → India — Nivolumab (Import)Other Nivolumab Routes
Unlock the Full India to United States Nivolumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 10 shipments on this route.
Frequently Asked Questions — India to United States Nivolumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Nivolumab to United States?
The leading Indian exporters of Nivolumab to United States are GNH India Pharmaceuticals Limited, DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED. GNH India Pharmaceuticals Limited holds the largest market share at approximately 73% of total trade value on this route.
Q What is the total value of Nivolumab exports from India to United States?
India exports Nivolumab to United States worth approximately $4.9K USD across 10 recorded shipments. The average value per shipment is $486 USD.
Q Which ports does India use to ship Nivolumab to United States?
The most active port of origin is AHEMDABAD AIR with 3 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 19% by air.
Q How long does shipping take from India to United States for Nivolumab?
The average transit time for Nivolumab shipments from India to United States is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Nivolumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.3% with demand growth tracking at 26.9%. The route is ranked #16 among India's top Nivolumab export destinations globally.
Q How many suppliers are active on the India to United States Nivolumab route?
There are currently 5 active Indian suppliers exporting Nivolumab to United States. The market is moderately concentrated with GNH India Pharmaceuticals Limited accounting for 73% of total shipment value.
Q Who are the main importers of Nivolumab from India in United States?
The leading importers of Indian Nivolumab in United States include NA, CHARLES RIVER LABORATORIES, BIOPHARMASPEC INC, CHARLES RIVER LABORATORIES,INC.,, NIIMBL ,RM 301 LIFE SCIENCE BUILDI. NA is the largest buyer with 1 shipments worth $3.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Nivolumab.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 6 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 10 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists